Pinion John Richard's Form 4 filing
Ultragenyx Pharmaceutical Inc. (RARE) · filed Mar 4, 2025
- Accession no.
- 0000950170-25-032785
- Filed
- Mar 4, 2025
- Trade date
- Mar 1-3, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $607.9K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pinion John RichardCIK 0001648096 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2025 | Common Stock | AGrant or awardAcquired | +14,494 | $0.00 | $0 | 103,762 | Direct | |
| Mar 1, 2025 | Common Stock | AGrant or awardAcquired | +18,443 | $0.00 | $0 | 122,205 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −14,439 | $42.10 | −$607,881.9 | 107,766 | Direct | |
| Mar 3, 2025 | Common Stock | FTax withholdingDisposed | −31 | $42.92 | −$1,330.52 | 108,428 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2025 | Commmon Stock | AGrant or awardAcquired | +26,074 | $0.00 | $0 | 26,074 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.